I get the flu shot every year...I never get the flu and I
I get the flu shot every year...I never get the flu and I reduce my risk of heart disease....I take the lead of the Mayo Clinic on this issue....they arent in a conspiracy with Big Pharma and Big Pharma doesnt want me to die anymore than Leo does..Im betting Big Pharma takes the IPIX portfolio of life saving drugs out to patients all over the world
from Mayo Clinic
Flu shots: Especially important if you have heart disease
If you have heart disease, flu shots can reduce your risk of flu-related complications. Discover the benefits of getting a flu shot and when to get one.
By Mayo Clinic Staff
If you have heart disease, flu season can be a dangerous time. Complications from influenza (flu) are more likely in people with heart disease. Fortunately, getting a flu shot can reduce your risk of catching the flu or developing complications from the flu.
While doctors have long recommended that older adults and other high-risk groups get flu shots, they're now emphasizing the importance of flu shots for those with heart disease too.
Why are flu shots important for those with heart disease?
If you have heart disease, you're at increased risk of complications from the flu — including pneumonia, respiratory failure, heart attack and death. Having the flu can also worsen pre-existing conditions, such as heart failure, diabetes or asthma.
Even if you get the flu despite having a flu shot, you'll probably have a less severe case of the flu. If you have heart disease, some research suggests that getting a flu shot might even lower your risk of a heart attack or other cardiovascular event, or death from a cardiovascular event. More research is needed to confirm this benefit, however.
It's also a good idea to get a flu shot if you live with or care for someone who has heart disease. Lowering your risk of getting the flu will lower the risk of those around you.
Is it safe to get a flu shot if I have heart disease?
Flu shots are safe for most people who have heart disease.
Flu vaccines are usually injected by needle into the upper extremity. Some people develop short-lived side effects, such as mild arm soreness at the injection site, a mild fever or muscle aches.
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...
Continue Reading
A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...
Continue Reading
A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...
Continue Reading
A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...
Continue Reading
A License Deal With Actual Cash Attached Drug licensing announcements can smell like expensive perfume: plenty of promise, hard to tell what is really in the bottle. This one at least arrives with a concrete number. Innogen Pharmaceuticals will receive US$38 million in upfront and near-term milestone payments from Arcera Life Sciences for Efsubaglutide Alfa, including a...
Continue Reading
A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...
Continue Reading
A haircut search is turning into a distribution fight, and Fresha has planted itself squarely in the middle of it. The company’s new Partner Network pushes its beauty and wellness marketplace beyond its own app and website into Google Search, Google Maps, Google’s AI experiences, ChatGPT, Claude, and eventually Alexa. That sounds like another glossy AI announcement...
Continue Reading
A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...
Continue Reading
A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...
Continue Reading
Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...
Continue Reading
Top 5 Most Recently Viewed Articles
Whataburger Announces CEO Retirement and Leadership Transition Whataburger is making headlines with the news that Chief Executive Officer Ed Nelson will retire at the end of this year. This marks the conclusion of a significant chapter in the company’s journey. Over his two-decade tenure, Ed's leadership has profoundly impacted Whataburger's growth and expansion. Ed...
Continue Reading
Understanding the Class Action Lawsuit for BigBear.ai Holdings, Inc. BigBear.ai Holdings, Inc. (NYSE: BBAI) is currently facing legal scrutiny as a class action lawsuit has been filed on behalf of shareholders who purchased the company's securities between specific periods of interest. Legal representatives are urging shareholders who believe they were adversely affected...
Continue Reading
Piramal Pharma Limited Announces Impressive Q2 and H1 FY25 Results Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a prominent player in the global pharmaceuticals and wellness industry, has reported its financial results for the Second Quarter (Q2) and Half Year (H1) of FY25, indicating a notable upward trend in its performance. Financial Highlights from Q2 FY25...
Continue Reading
Foresee Pharmaceuticals Advances Treatment Options for PH-ILD Foresee Pharmaceuticals has recently marked a significant milestone by announcing the dosing of the first patient in its Phase 2 WINDWARD study. This critical study aims to assess the efficacy and safety of mirivadelgat, a novel oral medication designed for individuals suffering from pulmonary...
Continue Reading
Suki's Impressive Funding Round Suki, an innovative healthcare startup, has successfully raised $70 million in its Series D funding round. This funding brings the company's total capital raised to an impressive $165 million. The news marks a significant step forward for Suki as it seeks to enhance its AI-assisted offerings aimed at reducing the administrative burdens...
Continue Reading